期刊文献+

胃癌术后复发致梗阻性黄疸的挽救治疗 被引量:1

Salvage therapy for postoperative obstruction jaundice of gastric cancer
下载PDF
导出
摘要 目的:总结胃癌术后复发引起的梗阻性黄疸的治疗。方法:回顾性分析2001-2010年我院收治的48例因胃癌术后复发所致梗阻性黄疸的资料。男性31例,女性17例。根治性切除术后42例,姑息性切除术后6例。黄疸发生于术后6个月以内、6-12个月(包括12个月)、13-24个月(包括24个月)、25个月及以上者分别为5例、14例、17例、12例。外科手术治疗12例,其中胆管空肠吻合4例,T管引流8例;经内镜放置胆道内支架7例;PTCD 17例;药物减黄治疗12例。34例经减黄治疗后行放、化疗综合治疗。结果:12例手术治疗者,2周内黄疸完全消退。7例经内镜置入内支架者,4周内黄疸完全消退率为85.7%。17例成功行PTCD患者4周内黄疸完全消退率为58.8%。12例黄疸较轻者药物治疗9例有效。全组患者中位生存期为7.5月,1年生存率为39.9%。结论:胃癌术后复发引起的梗阻性黄疸者愈后不佳;极积有效的减黄治疗可改善患者的生活质量,微创减黄可作为首选方法;对一般状态较好者,减黄后进行放、化疗综合治疗,有可能延长患者的生存期。 Objective: To summarize the treatment experience of obstructive jaundice in patients of recurrence gastric carcinoma. Methods:Total of 48 patients admitted from 2001 to 2010 with extrahepatie biliary obstruction caused by recurrence gastric cancer were retrospectively analyzed,31 of these cases were male and 17 were female, for which 42 cases underwent radical surgery and 6 cases palliative surgery in previous surgery. The jaundice emerged within 6 months,6 - 12 months,12 -24 months and more than 24 months in 5 cases,14 cases,17 cases and 12 cases respect from previous gastretomy. 12 patients underwent surgery procedures including choledochojejunostomy in 4 cases and insertion of T tube in 8 cases. 7 patients underwent endoscopic insertion of stent and 17 patients received biliary decompression by percutaneous transhepatic biliary drainage. For another 12 patients, they only received medicine treatment. Chemotherapy and/or radiotherapy were carried out in 34 patients after the jaundice vanished. Results: The jaundice was vanished within 2 weeks for all of the operative patients. Reduction in serum total bilirubin was seen in all patients,but only 85.7% and 58.8% respect for endoscopic stent insertion and percutaneous transhepatic biliary drainage cases reduced to normal level within 4 weeks. Serum total bilirubin decreasing was observed in 9 of the 12 minor jaundice patients received medicine treatment. Overall median survival was 7.5 months and 1 - year survival rate was 39.9%. Conclusion:The prognosis of obstructive jaundice due to recurrence gastric carcinoma is poor, adequate biliary drainage combined with appropriate chemotherapy/irradiation can improve the patient life quality and may prolong their survival time.
出处 《现代肿瘤医学》 CAS 2013年第2期356-358,共3页 Journal of Modern Oncology
基金 甘肃省国际科技合作计划(编号:090WCGA898)
关键词 胃肿瘤 胆道梗阻 挽救治疗 复发 黄疸 stomach neoplasms obstructive jaundice salvage therapy recurrence jaundice
  • 相关文献

参考文献4

二级参考文献36

  • 1彭淑牖,刘颖斌,李海军.胃癌术后梗阻性黄疸的再手术及有关问题[J].中国实用外科杂志,2004,24(7):395-396. 被引量:7
  • 2张茂,张显菖,方莉,杨冬园,杨玉梁,唐克俭.残胃癌外科治疗14例分析[J].中国实用外科杂志,2005,25(7):433-433. 被引量:1
  • 3许学杰,刘国泉.胃癌术后梗阻性黄疸[J].齐齐哈尔医学院学报,2005,26(10):1153-1154. 被引量:2
  • 4[1]Neuhaus H,Hagenmuller F,Griebel M,Classen M.Percutaneous cholangioscopic or transpapillary insertion of self-expanding biliary metal stents.Gastrointest Endosc 1991;37:31-37
  • 5[2]Huibregtse K,Cheng J,Coene PP,Fockens P,Tytgat GN.Endoscopic placement of expandable metal stents for biliary www.wjgnet.comstrictures--a preliminary report on experience with 33 patients.Endoscopy 1989; 21:280-282
  • 6[3]Rossi P,Bezzi M,Rossi M,Adam A,Cherty N,Roddie ME,Iacari V,Cwikiel W,Zollikofer CL,Antonucci F.Metallic stents in malignant biliary obstruction:results of a multicenter European study of 240 patients.J Vasc Interv Radiol 1994; 5:279-285
  • 7[4]Stoker J,Lameris JS.Complications of percutaneously inserted biliary Wallstents.J Vasc Interv Radiol 1993; 4:767-772
  • 8[5]Knyrim K,Wagner HJ,Pausch J,Vakil N.A prospective,randomized,controlled trial of metal stents for malignant obstruction of the common bile duct.Endoscopy 1993; 25:207-212
  • 9[6]Lee MJ,Dawson SL,Mueller PR,Krebs TL,Saini S,Hahn PF.Palliation of malignant bile duct obstruction with metallic biliary endoprostheses:technique,results,and complications.J Vasc Interv Radiol 1992; 3:665-671
  • 10[7]Yoshida H,Tajiri T,Mamada Y,Taniai N,Kawano Y,Mizuguchi Y,Yokomuro S,Uchida E,Arima Y,Akimaru K,Watanabe M,Uchida E.One-step insertion of an expandable metallic stent for unresectable common bile duct carcinoma.J Nippon Med Sch 2003; 70:179-182

共引文献47

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部